RecruitingNCT05783817
MDMA-assisted or methamphetamine-assisted CBT for OCD: safety and preliminary study
About this title
Read the official source — NCT05783817Medication studyAges 18+United States
Understand this study
Who could participate?
This study is for people with OCD. Listed age limits: from 18 years. Other eligibility criteria apply.
- Listed locations
- Palo AltoSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: September 10, 2025
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 40
- Sponsor
- Carolyn Rodriguez
- Sponsor type
- Unknown or unclear
- Study type
- Behavioral
- Intervention type
- Behavioural, Drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- Over 18 Years
- Official registry ID
- NCT05783817
- Official title
Show the full official title
MDMA-Assisted Cognitive Behavioral Therapy (CBT) Compared With Methamphetamine-Assisted CBT in Obsessive-Compulsive Disorder (OCD): A Phase II Study
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Palo Alto
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Carolyn Rodriguez.
Does this study involve medication?
Yes. The study involves medication, including 3,4-Methyl enedioxy methamphetamine and Methamphetamine.
Who can participate?
This study is for people with OCD. Listed age limits: from 18 years. Other eligibility criteria apply.
Is this study still recruiting?
The registry lists this study as recruiting.
